Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Jiang, Jing ^a,b,c   Chen, Xinchun ^a,d   An, Hongjuan ^b   Yang, Bingfen ^b   Zhang, Fuping ^c   Cheng, Xiaoxing ^b  

^a SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^b 309TH HOSPITAL OF PLA   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

^d Shenzhen University School of Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; GAMMA INTERFERON; GRANZYME; IL17F PROTEIN, HUMAN; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 18 PROTEIN, HUMAN; INTERLEUKIN 2; LIPOPOLYSACCHARIDE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; ANTAGONISTS AND INHIBITORS; CELLULAR IMMUNITY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MALE; MICROBIOLOGY; MUCOSAL-ASSOCIATED INVARIANT T CELL; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; PATHOLOGY; PLEURA EFFUSION; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION; TUBERCULOUS PLEURISY;

ADULT; ANTIBODIES, BLOCKING; FEMALE; GENE EXPRESSION REGULATION; GRANZYMES; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-17; INTERLEUKIN-18; INTERLEUKIN-2; LIPOPOLYSACCHARIDE RECEPTORS; MALE; MUCOSAL-ASSOCIATED INVARIANT T CELLS; MYCOBACTERIUM TUBERCULOSIS; PLEURAL EFFUSION; PRIMARY CELL CULTURE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; TUBERCULOSIS, PLEURAL;

EID: 84986237848     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32320     Document Type: Article

References (53)

1. WHO. Global tuberculosis report 2014. http://www. who. int/tb/publications/global-report/en/(2015).
2. Vorster, M. J., Allwood, B. W., Diacon, A. H. & Koegelenberg, C. F. Tuberculous pleural effusions: advances and controversies. J Thorac Dis 7, 981-991 (2015).
3. Udwadia, Z. F. & Sen, T. Pleural tuberculosis: an update. Curr Opin Pulm Med 16, 399-406 (2010).
4. Light, R. W. Update on tuberculous pleural effusion. Respirology 15, 451-458 (2010).
5. Le Bourhis, L. et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11, 701-708 (2010).
6. Gold, M. C. et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 8, e1000407 (2010).
7. Le Bourhis, L. et al. MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog 9, e1003681 (2013).
8. Kurioka, A. et al. MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol 8, 429-440 (2015).
9. Meierovics, A., Yankelevich, W. J. & Cowley, S. C. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci USA 110, E3119-E3128 (2013).
10. Howson, L. J., Salio, M. & Cerundolo, V. MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases. Front Immunol 6, 303 (2015).
11. Reantragoon, R. et al. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J Exp Med 209, 761-774 (2012).
12. Patel, O. et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun 4, 2142 (2013).
13. Reantragoon, R. et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med 210, 2305-2320 (2013).
14. Gold, M. C. et al. MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage. J Exp Med 211, 1601-1610 (2014).
15. Lepore, M. et al. Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRbeta repertoire. Nat Commun 5, 3866 (2014).
16. Corbett, A. J. et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509, 361-365 (2014).
17. Kjer-Nielsen, L. et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717-723 (2012).
18. Soudais, C. et al. In Vitro and In Vivo Analysis of the Gram-Negative Bacteria-Derived Riboflavin Precursor Derivatives Activating Mouse MAIT Cells. J Immunol 194, 4641-4649 (2015).
19. Rahimpour, A. et al. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med 212, 1095-1108 (2015).
20. Sakala, I. G. et al. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. J Immunol 195, 587-601 (2015).
21. Treiner, E. et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422, 164-169 (2003).
22. Gapin, L. Check MAIT. J Immunol 192, 4475-4480 (2014).
23. Chua, W. J. et al. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun 80, 3256-3267 (2012).
24. Jiang, J. et al. Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis. Am J Respir Crit Care Med 190, 329-339 (2014).
25. Kwon, Y. S. et al. Mucosal-associated invariant T cells are numerically and functionally deficient in patients with mycobacterial infection and reflect disease activity. Tuberculosis (Edinb) 95, 267-274 (2015).
26. Leeansyah, E. et al. Activation, exhaustion, persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 121, 1124-1135 (2013).
27. Cosgrove, C. et al. Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood 121, 951-961 (2013).
28. Fernandez, C. S. et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol 93, 177-188 (2015).
29. Magalhaes, I. et al. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest 125, 1752-1762 (2015).
30. Cho, Y. N. et al. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J Immunol 193, 3891-3901 (2014).
31. Jasenosky, L. D., Scriba, T. J., Hanekom, W. A. & Goldfeld, A. E. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev 264, 74-87 (2015).
32. Lin, P. L. & Flynn, J. L. CD8 T cells and Mycobacterium tuberculosis infection. Semin Immunopathol 37, 239-249 (2015).
33. Behar, S. M., Carpenter, S. M., Booty, M. G., Barber, D. L. & Jayaraman, P. Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus. Semin Immunol 26, 559-577 (2014).
34. Ernst, J. D. The immunological life cycle of tuberculosis. Nat Rev Immunol 12, 581-591 (2012).
35. Bhatt, K., Verma, S., Ellner, J. J. & Salgame, P. Quest for correlates of protection against tuberculosis. Clin Vaccine Immunol 22, 258-266 (2015).
36. Orme, I. M., Robinson, R. T. & Cooper, A. M. The balance between protective and pathogenic immune responses in the TB-infected lung. Nat Immunol 16, 57-63 (2015).
37. Weiss, G. & Schaible, U. E. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev 264, 182-203 (2015).
38. Kaufmann, S. H. & Dorhoi, A. Inflammation in tuberculosis: interactions, imbalances and interventions. Curr Opin Immunol 25, 441-449 (2013).
39. Jiang, J. et al. Mucosal-associated invariant T cells from patients with tuberculosis exhibit impaired immune response. J Infect 72, 338-352 (2016).
40. Ussher, J. E. et al. CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+ IL-18 in a TCRindependent manner. Eur J Immunol 44, 195-203 (2014).
41. Jo, J. et al. Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver. PLoS Pathog 10, e1004210 (2014).
42. Sattler, A., Dang-Heine, C., Reinke, P. & Babel, N. IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions. Eur J Immunol 45, 2286-2298 (2015).
43. Tang, X. Z. et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol 190, 3142-3152 (2013).
44. Liao, W., Lin, J. X. & Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, immunotherapy. Immunity 38, 13-25 (2013).
45. Liao, W., Lin, J. X. & Leonard, W. J. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23, 598-604 (2011).
46. Gaffen, S. L. Signaling domains of the interleukin 2 receptor. Cytokine 14, 63-77 (2001).
47. Vignali, D. A. & Kuchroo, V. K. IL-12 family cytokines: immunological playmakers. Nat Immunol 13, 722-728 (2012).
48. Schurich, A. et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog 9, e1003208 (2013).
49. van de Vosse, E. et al. IL-12Rbeta1 deficiency: mutation update and description of the IL12RB1 variation database. Hum Mutat 34, 1329-1339 (2013).
50. Villarino, A. V., Kanno, Y., Ferdinand, J. R. & O'Shea, J. J. Mechanisms of Jak/STAT signaling in immunity and disease. J Immunol 194, 21-27 (2015).
51. Morrison, D. K. MAP kinase pathways. Cold Spring Harb Perspect Biol 4; DOI: 10. 1101/cshperspect. a011254 (2012).
52. Cook, R., Wu, C. C., Kang, Y. J. & Han, J. The role of the p38 pathway in adaptive immunity. Cell Mol Immunol 4, 253-259 (2007).
53. Jiang, J. et al. Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis. J Clin Immunol 30, 566-573 (2010).